v3.26.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities:    
Net loss $ (9,159) $ (3,022)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of deferred compensation 20
Stock-based compensation expense 4,519 1,893
Depreciation and amortization expense 451 415
Amortization of discount on convertible notes 715
Changes in fair value of derivative liabilities 278
Changes in operating assets and liabilities:    
Accounts receivable 622 (902)
Prepaids and other current assets (332) (611)
Other assets (7)
Accounts payable (20) 44
Accrued expenses and other current liabilities 660 22
Net cash used in operating activities (3,266) (1,148)
Investing activities:    
Purchase of equipment (646) (161)
Net cash used in investing activities (646) (161)
Financing activities:    
Proceeds from stock option exercise 104 25
Proceeds from stock warrant exercise 708
Proceeds from convertible notes issuance 3,145
Proceeds from public offerings, net of offering costs 43,478 12,588
Payment for taxes related to net share settlement of stock options and restricted stock units (112)
Net cash provided by financing activities 44,178 15,758
Net change in cash and cash equivalents, and certificate of deposit 40,266 14,449
Cash and cash equivalents, and certificate of deposit, beginning of period 15,740 1,291
Cash and cash equivalents, and certificate of deposit, end of period 56,006 15,740
Supplemental non-cash disclosures:    
Right of use asset - operating obtained in exchange for lease liability -operating 1,014
Conversion of convertible notes to stockholders’ equity 1,667
Conversion of derivative liabilities to stockholders’ equity $ 2,471

Source